HEFFLER, Enrico Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.754
EU - Europa 1.637
AS - Asia 432
AF - Africa 266
OC - Oceania 40
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.167
Nazione #
US - Stati Uniti d'America 6.676
FI - Finlandia 379
IE - Irlanda 310
NG - Nigeria 259
DE - Germania 235
CN - Cina 176
IT - Italia 169
FR - Francia 131
NL - Olanda 116
CA - Canada 69
GB - Regno Unito 69
SE - Svezia 67
IN - India 52
TW - Taiwan 39
AU - Australia 36
TR - Turchia 35
BE - Belgio 31
BR - Brasile 24
RU - Federazione Russa 24
HK - Hong Kong 22
CH - Svizzera 21
ES - Italia 21
KR - Corea 21
SG - Singapore 19
IL - Israele 18
JP - Giappone 15
CZ - Repubblica Ceca 9
MX - Messico 8
RO - Romania 8
ID - Indonesia 7
NO - Norvegia 7
PK - Pakistan 6
PL - Polonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
DK - Danimarca 5
GR - Grecia 5
SA - Arabia Saudita 5
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
GM - Gambi 3
IR - Iran 3
MY - Malesia 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
UA - Ucraina 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DZ - Algeria 1
IQ - Iraq 1
LV - Lettonia 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 9.167
Città #
Chandler 1.322
Wilmington 1.289
San Mateo 482
Ann Arbor 415
Helsinki 377
Dublin 291
Benin City 259
Lawrence 234
Princeton 234
Leawood 221
Boardman 214
New York 155
Shanghai 150
Fairfield 124
Ashburn 114
Woodbridge 107
Paris 106
Amsterdam 92
Toronto 57
London 49
San Diego 35
Redwood City 34
Kocaeli 30
Norwalk 30
Brussels 28
Menlo Park 28
Santa Clara 27
Seattle 25
Pune 22
Monmouth Junction 21
Newark 17
Phoenix 16
Falls Church 15
Milan 14
Houston 11
Melbourne 11
Moscow 10
Munich 10
Redmond 10
Singapore 10
Prague 9
Des Moines 8
Pergine Valsugana 8
Rome 8
Cambridge 7
Falkenstein 7
Genoa 7
Hyderabad 7
Jakarta 7
Philadelphia 7
Secaucus 7
Wageningen 7
Beijing 6
Meppel 6
Abbiategrasso 5
Berlin 5
Central District 5
Elk Grove Village 5
Frankfurt am Main 5
Halle 5
Mountain View 5
Taipei 5
Tappahannock 5
Torino 5
Zhengzhou 5
Andover 4
Barcelona 4
Bochum 4
Florianópolis 4
Hong Kong 4
Los Angeles 4
Lutz 4
Marburg 4
Ottawa 4
Pescia 4
Rochester 4
Sydney 4
Tokushima 4
Uetikon Am See 4
Zafra 4
Örebro 4
Auckland 3
Bangalore 3
Braunschweig 3
Central 3
Flinders 3
Genova 3
Ghaziabad 3
Hanoi 3
Hefei 3
Lehi 3
Rajkot 3
Rio De Janeiro 3
San Mauro Torinese 3
St Petersburg 3
Tokyo 3
Toulouse 3
Vienna 3
Augusta 2
Bangkok 2
Totale 6.971
Nome #
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 213
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 203
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 91
Research needs in allergy: an EAACI position paper, in collaboration with EFA 87
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 87
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 87
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 86
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 81
A critical appraisal on AIT in childhood asthma. 76
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 74
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 67
An academic allergy unit during COVID-19 pandemic in Italy. 66
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 66
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 65
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 64
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 60
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 57
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 56
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 55
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 55
Unexplained chronic cough and vitamin B-12 deficiency. 55
Nasal cytology: Methodology with application to clinical practice and research. 54
Anaphylaxis after a horse bite 54
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 53
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 53
Allergy in severe asthma. 53
Adherence issues related to sublingual immunotherapy as perceived by allergists. 53
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 53
Allergy in internet 53
Determinants of exhaled nitric oxide in chronic rhinosinusitis 52
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 52
Level of exhaled nitric oxide during human anaphylaxis 52
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 52
Microarray Immunodiagnostics for Aeroallergens 52
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 52
Unexpected visitor: “hidden” food allergens 50
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 50
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 50
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 50
Strategies to reduce corticosteroid-related adverse events in asthma 50
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 50
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 49
Real-life studies of biologics used in asthma patients: key differences and similarities to trials. 49
Acute urticaria presenting in the emergency room of a general hospital 49
One year of mepolizumab. Efficacy and safety in real-life in Italy. 49
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 49
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 49
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 49
TNF-alpha: a promising therapeutic target for asthma? 48
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 48
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 48
Nasal nitric oxide in patients with inherited retinal dystrophies. 48
Acute asthma management during SARS-CoV2-pandemic 2020 48
Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting of chronic cough 46
Interleukin-5 in the Pathophysiology of Severe Asthma. 46
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 46
Treatable traits in chronic rhinosinusitis with nasal polyps 46
Minimal clinically important difference for asthma endpoints: an expert consensus report 46
Asthma from immune pathogenesis to precision medicine. 45
Exhaled nitric oxide in asthma. 44
The Severe Asthma Network in Italy: Findings and Perspectives. 44
Thunderstorm-related asthma epidemic owing to Olea Europaea pollen sensitization. 44
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 44
Omalizumab Treatment of Vernal Keratoconjunctivitis 44
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 44
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis 44
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 44
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 44
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 43
Inhaled corticosteroids safety and adverse effects in patients with asthma 43
Asthma: personalized and precision medicine 43
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 43
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 43
Basophil activation test: a reliable biomarker for allergen immunotherapy? 42
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 42
Current insights in allergen immunotherapy. 42
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study. 42
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 42
Exhaled nitric oxide in persistent rhinitis with or without lower airway involvement: a review of the literature. 42
Exhaled nitric oxide as a marker of diseases 42
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 41
Exhaled nitric oxide's ability to predict methacholine challenge: a matter of definition 41
The pathway towards asthma control 41
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 41
Eosinophils Target Therapy for Severe Asthma: Critical Points 41
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 41
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 41
Basophil Membrane Expression of Epithelial Cytokine Receptors in Patients with Severe Asthma. 41
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 41
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 40
Effect of arterial hypertension on chronic urticaria duration 40
EUFOREA consensus on biologics for CRSwNP with or without asthma. 40
Exhaled nitric oxide (F(E)NO) in non-pulmonary diseases 40
Immunostimulants in respiratory diseases: focus on Pidotimod. 40
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 40
Alpha1-antitrypsin deficiency and asthma 40
Exhaled NO in diffuse alveolar haemorrhage 39
Occupational asthma due to Neurospora sitophila sensitization in a coffee dispenser service operator 39
Kounis syndrome: Aspects on pathophysiology and management 39
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 39
Totale 5.357
Categoria #
all - tutte 63.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 0 0 0 0 0 27
2020/20212.629 35 80 47 28 23 781 345 228 467 311 43 241
2021/20221.422 62 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20241.552 183 242 437 66 114 184 90 136 63 37 0 0
Totale 9.311